KTTA
Pasithea Therapeutics Corp. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Pasithea Therapeutics (KTTA) Stock: Buy, Sell, or Hold?
$0.57
+0.03 (+5.81%)
▲
5d:
+8.26%
30d:
+28.22%
90d:
+17.1%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
26/100
Position
EXTENDED
30-Day Fair Range
$0.39 – $0.48
Position: EXTENDED
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$3.00
+422.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.35 / $0.61
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: KTTA is 19.5% above its trading range ($0.48). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When KTTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KTTA is currently trading at $0.57, which is considered extended relative to its 30-day fair value range of $0.39 to $0.48.
Technical Outlook: Technically, KTTA is in a downtrend. Immediate support is located at $0.35, while resistance sits at $0.61. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: KTTA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+422.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KTTA is in a downtrend. Immediate support is located at $0.35, while resistance sits at $0.61. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: KTTA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+422.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.39 -
$0.48
Company Quality Score
26/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$0.39 -
$0.48
Current vs Trading Range
EXTENDED
Support Level
$0.35
Resistance Level
$0.61
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+19.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 422.8% below Wall St target ($3.00)
- WARNING: Composite score 26/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.25
Wall Street Target
$3.00
(+422.8%)
Revenue Growth (YoY)
1498.1%
Share KTTA Analysis
Share this live KTTA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KTTA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
According to a bullish StockTwits user with 205 followers, $KTTA has performed well in the market despite downturns, with impressive one-week gains following FDA approval.
Key Retail Themes:
Stock performance
FDA approval
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KTTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KTTA Research Pages
